Xiyu Liu

机构：Shanghai Jiao Tong University, Fudan University Shanghai Cancer Center · ORCID：0000-0002-3882-4609

发表论文 97 篇 · 总被引 2141 次 · h-index 27

代表论文

• Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients (2025 · Cell · 被引 94)
• Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial (2024 · The Lancet Oncology · 被引 69)
• Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage (2024 · Phytomedicine · 被引 45)
• Paeonol inhibits ACSL4 to protect chondrocytes from ferroptosis and ameliorates osteoarthritis progression (2024 · Journal of Orthopaedic Translation · 被引 22)
• A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles (2025 · Theranostics · 被引 16)
• Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial (2024 · BMJ · 被引 15)